13F-HR filed by Prosight Management, LP
Prosight Management, LP filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 46 holding rows worth $334,574,049.
- Accession
- 0001420506-24-001439
- Filer
- CIK 1617201
- Filed
- 2024-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2024
A holdings report, 46 entries on the cover page, a total value of $334,574,049 stated on the cover page (in dollars after the unit check, H1), rows summing to $334,574,049 with VALUE read as dollars as filed, 13F file number 028-18450. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| LAKEFRONT BIOTHERAPEUTICS NV | 36315X101 | SPON ADR | 1,349,980 | $33,452,504 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 9,570,000 | $30,241,200 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 2,000,000 | $21,140,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 800,000 | $20,264,000 | dollars as filed | |
| ZIMMER BIOMET HOLDINGS INC COM | 98956P102 | Stock | 170,000 | $18,450,100 | dollars as filed | |
| MEIRAGTX HOLDINGS PLC | G59665102 | COMMON STOCK | 4,352,700 | $18,324,867 | dollars as filed | |
| SHATTUCK LABS INC | 82024L103 | COMMON STOCK | 4,670,000 | $18,026,200 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 629,900 | $12,969,641 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 230,000 | $12,461,400 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 551,544 | $11,323,198 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 314,800 | $10,763,012 | dollars as filed | |
| KELLY SVCS INC | 488152208 | CL A | 492,340 | $10,540,999 | dollars as filed | |
| ZYMEWORKS INC | 98985Y108 | COM | 1,180,000 | $10,041,800 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 325,000 | $8,580,000 | dollars as filed | |
| SCHRODINGER INC COM | 80810D103 | Stock | 369,261 | $7,141,508 | dollars as filed | |
| ABCELLERA BIOLOGICS INC COM | 00288U106 | Stock | 2,352,633 | $6,963,794 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 275,000 | $6,627,500 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 2,750,000 | $6,490,000 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 115,000 | $6,096,150 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 286,926 | $5,922,153 | dollars as filed | |
| ORTHOPEDIATRICS CORP | 68752L100 | COMMON STOCK | 200,216 | $5,758,212 | dollars as filed | |
| OPTION CARE HEALTH INC COM NEW | 68404L201 | Stock | 205,000 | $5,678,500 | dollars as filed | |
| DEXCOM INC COM | 252131107 | Stock | 49,317 | $5,591,561 | dollars as filed | |
| ACCOLADE INC | 00437E102 | COM | 1,489,525 | $5,332,500 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 500,000 | $4,215,000 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 27,000 | $3,717,090 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 385,000 | $2,510,200 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 398,700 | $2,463,966 | dollars as filed | |
| CVS Health Corporation | 126650100 | COM | 40,000 | $2,362,400 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 30,000 | $2,361,300 | dollars as filed | |
| VINCERX PHARMA INC | 92731L106 | COM NEW | 2,488,418 | $2,015,619 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 14,000 | $1,873,620 | dollars as filed | |
| PARAGON 28 INC | 69913P105 | COM | 261,400 | $1,787,976 | dollars as filed | |
| UNIVERSAL HLTH SVCS INC CL B | 913903100 | Stock | 9,373 | $1,733,349 | dollars as filed | |
| PRIVIA HEALTH GROUP INC | 74276R102 | COM | 96,065 | $1,669,610 | dollars as filed | |
| MURAL ONCOLOGY PUB LTD CO | G63365103 | ORD SHS | 475,458 | $1,492,938 | dollars as filed | |
| ADDUS HOMECARE CORP | 006739106 | COM | 12,500 | $1,451,375 | dollars as filed | |
| TECTONIC THERAPEUTIC INC | 878972108 | COMMON STOCK | 67,461 | $1,111,083 | dollars as filed | |
| LENZ THERAPEUTICS INC | 52635N103 | COM | 59,542 | $1,029,481 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 49,021 | $953,458 | dollars as filed | |
| OVID THERAPEUTICS INC | 690469101 | COMMON STOCK | 1,075,000 | $826,890 | dollars as filed | |
| IMMUNOME INC | 45257U108 | COM | 65,000 | $786,500 | dollars as filed | |
| REIN THERAPEUTICS INC | 00887A204 | COM NEW | 265,000 | $734,050 | dollars as filed | |
| IMMUNEERING CORP | 45254E107 | CLASS A COM | 550,000 | $704,000 | dollars as filed | |
| BIOMEA FUSION INC | 09077A106 | CMN | 124,377 | $559,697 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 56,080 | $33,648 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-24-001439 | this filing | 2024-08-14 | acceptance time not in the bulk data set |